Since 2005 we've been closely involved in the brand development of one of the leading treatments for breast cancer in post-menopausal women, AstraZeneca's Arimidex.

Initially appointed to develop visual concepts and a key communication message for the brand, we've since been involved in further positioning and key message development work, along with the creation of integrated campaign materials to support consistent local implementation around the world, for example advertising, exhibition material and sales campaign frameworks.

Our work on Arimidex led us to work on the entire global oncology portfolio, recently developing an innovative exhibition eDetail platform for international congresses. We are also a lead agency on the development of the representative eDetail guidelines.